1. Home
  2. KMDA vs ALF Comparison

KMDA vs ALF Comparison

Compare KMDA & ALF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • ALF
  • Stock Information
  • Founded
  • KMDA 1990
  • ALF 2024
  • Country
  • KMDA Israel
  • ALF United States
  • Employees
  • KMDA N/A
  • ALF N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • ALF
  • Sector
  • KMDA Health Care
  • ALF
  • Exchange
  • KMDA Nasdaq
  • ALF NYSE
  • Market Cap
  • KMDA 399.7M
  • ALF 379.1M
  • IPO Year
  • KMDA N/A
  • ALF 2024
  • Fundamental
  • Price
  • KMDA $7.74
  • ALF $10.52
  • Analyst Decision
  • KMDA Strong Buy
  • ALF
  • Analyst Count
  • KMDA 3
  • ALF 0
  • Target Price
  • KMDA $14.67
  • ALF N/A
  • AVG Volume (30 Days)
  • KMDA 83.7K
  • ALF 37.7K
  • Earning Date
  • KMDA 08-13-2025
  • ALF 01-01-0001
  • Dividend Yield
  • KMDA 2.56%
  • ALF N/A
  • EPS Growth
  • KMDA 31.21
  • ALF N/A
  • EPS
  • KMDA 0.28
  • ALF 0.37
  • Revenue
  • KMDA $167,235,000.00
  • ALF N/A
  • Revenue This Year
  • KMDA $14.51
  • ALF N/A
  • Revenue Next Year
  • KMDA $9.31
  • ALF N/A
  • P/E Ratio
  • KMDA $27.53
  • ALF $28.31
  • Revenue Growth
  • KMDA 11.83
  • ALF N/A
  • 52 Week Low
  • KMDA $4.93
  • ALF $9.96
  • 52 Week High
  • KMDA $9.16
  • ALF $10.64
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 66.78
  • ALF N/A
  • Support Level
  • KMDA $7.68
  • ALF N/A
  • Resistance Level
  • KMDA $7.86
  • ALF N/A
  • Average True Range (ATR)
  • KMDA 0.21
  • ALF 0.00
  • MACD
  • KMDA 0.05
  • ALF 0.00
  • Stochastic Oscillator
  • KMDA 67.61
  • ALF 0.00

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About ALF CENTURION ACQUISITION CORP

Centurion Acquisition Corp is a blank check company.

Share on Social Networks: